A recent study undertaken at Rovira i Virgili University in Tarragona, Spain, reveals that biolabelling through luminescence thermometry has the potential to detect cancer cells at an early stage of development, just by monitoring the temperature rise in the body, due to accelerated metabolic activities in abnormal cells.
The Linkam THMS600 stage was used by researchers at the university to study the fluorescence of the nanoparticles that are produced.
